Current Clinical Pharmacology

Continued as Current Reviews in Clinical and Experimental Pharmacology

Editor-in-Chief

Arduino A. Mangoni
Flinders University and Flinders Medical Centre
Adelaide, SA
(Australia)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 2 Issue: 1, January

Misoprostol for the Treatment of Early Pregnancy Failure

Volume:2   Issue: 1
Pp: 1-9
Sheila A Doggrel
DOI: 10.2174/157488407779422267
Published on: 01 March, 2012

Warfarin Dosing and the Promise of Pharmacogenomics

Volume:2   Issue: 1
Pp: 11-21
Todd E. Dumas, Roy L Hawke and Craig R. Lee
DOI: 10.2174/157488407779422276
Published on: 01 March, 2012

Determinants of Drug Metabolism in Early Neonatal Life

Volume:2   Issue: 1
Pp: 23-29
Karel Allegaert, John N. van den Anker, Gunnar Naulaers and Jan de Hoon
DOI: 10.2174/157488407779422294
Published on: 01 March, 2012

The True Face of the Revolution in Oncology Drug Development: A Personal Reflection

Volume:2   Issue: 1
Pp: 31-35
Michael Burgess and Dinesh P. de Alwis
DOI: 10.2174/157488407779422258
Published on: 01 March, 2012

Clinical Pharmacokinetics of Systemically Administered Antimycotics

Volume:2   Issue: 1
Pp: 37-58
Romuald Bellmann
DOI: 10.2174/157488407779422311
Published on: 01 March, 2012

Immunomodulatory Therapy Associated to Anti-Parasite Drugs as a Way to Prevent Severe Forms of Malaria

Volume:2   Issue: 1
Pp: 59-73
Maria Imaculada Muniz-Junqueira
DOI: 10.2174/157488407779422285
Published on: 01 March, 2012

Busulphan in Blood and Marrow Transplantation: Dose, Route, Frequency and Role of Therapeutic Drug Monitoring

Volume:2   Issue: 1
Pp: 75-91
Christa Ellen Nath and Peter John Shaw
DOI: 10.2174/157488407779422249
Published on: 01 March, 2012

The Pharmacogenetics of CYP2C9 and CYP2C19: Ethnic Variation and Clinical Significance

Volume:2   Issue: 1
Pp: 93-109
J. Rosemary and C. Adithan
DOI: 10.2174/157488407779422302
Published on: 01 March, 2012